Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
17,711,768
-
Shares change
-
-666,080
-
Total reported value, excl. options
-
$73,144,106
-
Value change
-
-$3,356,008
-
Put/Call ratio
-
137%
-
Number of buys
-
21
-
Number of sells
-
24
-
Price
-
$4.13
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2016
61 filings reported holding ABUS - Arbutus Biopharma Corp - Common Shares, without par value as of 31 Mar 2016.
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,711,768 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, Falcon Edge Capital LP, HealthCor Management, L.P., D. E. Shaw & Co., Inc., SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, AXA, GOLDMAN SACHS GROUP INC, and SPHERA FUNDS MANAGEMENT LTD..
This table shows the top 47 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.